The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A dose-escalating and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer.
L. K. Martin
No relevant relationships to disclose
G. Jia
No relevant relationships to disclose
X. Yang
No relevant relationships to disclose
J. C. Grecula
No relevant relationships to disclose
E. J. Harper
No relevant relationships to disclose
C. Kefauver
No relevant relationships to disclose
L. Wei
No relevant relationships to disclose
Z. K. Shah
No relevant relationships to disclose
M. Bloomston
No relevant relationships to disclose
W. S. Melvin
No relevant relationships to disclose
P. Muscarella
No relevant relationships to disclose
E. C. Ellison
No relevant relationships to disclose
M. V. Knopp
No relevant relationships to disclose
I. Espinoza Delgado
No relevant relationships to disclose
M. R. Grever
No relevant relationships to disclose
T. S. Bekaii-Saab
No relevant relationships to disclose